453 related articles for article (PubMed ID: 17582567)
1. The use of typhoid vaccines in Asia: the DOMI experience.
Ochiai RL; Acosta CJ; Agtini M; Bhattacharya SK; Bhutta ZA; Do CG; Dong B; Chen X; Stanton B; Kaljee L; Nyamete A; Galindo CM; von Seidlein L; DeRoeck D; Jodar L; Clemens JD
Clin Infect Dis; 2007 Jul; 45 Suppl 1():S34-8. PubMed ID: 17582567
[TBL] [Abstract][Full Text] [Related]
2. The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia.
Acosta CJ; Galindo CM; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Park JK; Park E; Koo H; Wang XY; Abu-Elyazeed R; Ali M; Albert MJ; Ivanoff B; Pang T; Xu ZY; Clemens JD
J Health Popul Nutr; 2004 Sep; 22(3):240-5. PubMed ID: 15609776
[TBL] [Abstract][Full Text] [Related]
3. Typhoid vaccination: the Asian experience.
DeRoeck D; Ochiai RL; Yang J; Anh DD; Alag V; Clemens JD
Expert Rev Vaccines; 2008 Jul; 7(5):547-60. PubMed ID: 18564010
[TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries.
Cook J; Jeuland M; Whittington D; Poulos C; Clemens J; Sur D; Anh DD; Agtini M; Bhutta Z;
Vaccine; 2008 Nov; 26(50):6305-16. PubMed ID: 18835415
[TBL] [Abstract][Full Text] [Related]
5. Costs of illness due to typhoid fever in an Indian urban slum community: implications for vaccination policy.
Bahl R; Sinha A; Poulos C; Whittington D; Sazawal S; Kumar R; Mahalanabis D; Acosta CJ; Clemens JD; Bhan MK
J Health Popul Nutr; 2004 Sep; 22(3):304-10. PubMed ID: 15609783
[TBL] [Abstract][Full Text] [Related]
6. A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and design.
Acosta CJ; Galindo CM; Ali M; Elyazeed RA; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Jin Y; Park JK; Lee H; Puri MK; Ivanoff B; Agtini MD; Soeharno R; Simanjuntak CH; Punjabi NH; Canh DG; Sur D; Nizami Q; Manna B; Bai-qing D; Anh DD; Honghui Y; Bhattacharya SK; Bhutta Z; Trach DD; Xu ZY; Pang T; Donner A; Clemens JD
Trop Med Int Health; 2005 Dec; 10(12):1219-28. PubMed ID: 16359401
[TBL] [Abstract][Full Text] [Related]
7. An optimization model for reducing typhoid cases in developing countries without increasing public spending.
Lauria DT; Maskery B; Poulos C; Whittington D
Vaccine; 2009 Mar; 27(10):1609-21. PubMed ID: 19146902
[TBL] [Abstract][Full Text] [Related]
8. A cost-benefit analysis of typhoid fever immunization programmes in an Indian urban slum community.
Poulos C; Bahl R; Whittington D; Bhan MK; Clemens JD; Acosta CJ
J Health Popul Nutr; 2004 Sep; 22(3):311-21. PubMed ID: 15609784
[TBL] [Abstract][Full Text] [Related]
9. Sociobehavioural research methods for the introduction of vaccines in the Diseases of the Most Impoverished Programme.
Kaljee LM; Pack R; Pach A; Nyamete A; Stanton BF
J Health Popul Nutr; 2004 Sep; 22(3):293-303. PubMed ID: 15609782
[TBL] [Abstract][Full Text] [Related]
10. Typhoid vaccine: a case for inclusion in national program.
Sharma P; Taneja DK
Indian J Public Health; 2011; 55(4):267-71. PubMed ID: 22298135
[TBL] [Abstract][Full Text] [Related]
11. New generation typhoid vaccines: an effective preventive strategy to control typhoid fever in developing countries.
Verma R; Bairwa M; Chawla S; Prinja S; Rajput M
Hum Vaccin; 2011 Aug; 7(8):883-5. PubMed ID: 21791973
[TBL] [Abstract][Full Text] [Related]
12. Multidisciplinary studies of disease burden in the Diseases of the Most Impoverished Programme.
Deen JL; von Seidlein L; Clemens JD
J Health Popul Nutr; 2004 Sep; 22(3):232-9. PubMed ID: 15609775
[TBL] [Abstract][Full Text] [Related]
13. Typhoid fever in children aged less than 5 years.
Sinha A; Sazawal S; Kumar R; Sood S; Reddaiah VP; Singh B; Rao M; Naficy A; Clemens JD; Bhan MK
Lancet; 1999 Aug; 354(9180):734-7. PubMed ID: 10475185
[TBL] [Abstract][Full Text] [Related]
14. Vaccination against typhoid fever: present status.
Ivanoff B; Levine MM; Lambert PH
Bull World Health Organ; 1994; 72(6):957-71. PubMed ID: 7867143
[TBL] [Abstract][Full Text] [Related]
15. Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia.
DeRoeck D; Clemens JD; Nyamete A; Mahoney RT
Vaccine; 2005 Apr; 23(21):2762-74. PubMed ID: 15780724
[TBL] [Abstract][Full Text] [Related]
16. Live oral TY 21a--typhoid vaccine.
Bhatia RS
J Assoc Physicians India; 1993 Nov; 41(11):770, 773. PubMed ID: 8005959
[No Abstract] [Full Text] [Related]
17. Typhoid fever vaccination strategies.
Date KA; Bentsi-Enchill A; Marks F; Fox K
Vaccine; 2015 Jun; 33 Suppl 3(Suppl 3):C55-61. PubMed ID: 25902360
[TBL] [Abstract][Full Text] [Related]
18. Introducing Vi polysaccharide typhoid fever vaccine to primary school children in North Jakarta, Indonesia, via an existent school-based vaccination platform.
Agtini MD; Ochiai RL; Soeharno R; Lee HJ; Sundoro J; Hadinegoro SR; Han OP; Tana L; Halim FX; Ghani L; Delima ; Lestari W; Sintawati FX; Kusumawardani N; Malik R; Santoso TS; Nadjib M; Soeroso S; Wangsasaputra F; Ali M; Ivanoff B; Galindo CM; Pang T; Clemens JD; Suwandono A; Acosta CJ
Public Health; 2006 Nov; 120(11):1081-7. PubMed ID: 17005220
[TBL] [Abstract][Full Text] [Related]
19. Compatible concurrent administration of yellow fever 17D vaccine with oral, live, attenuated p6olera CVD103-HgR and typhoid ty21a vaccines.
Tsai TF; Kollaritsch H; Que JU; Cropp CB; Kunz C; Wiedermann G; Herzog C; Cryz SJ
J Infect Dis; 1999 Feb; 179(2):522-4. PubMed ID: 9878043
[No Abstract] [Full Text] [Related]
20. An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine.
Yang HH; Kilgore PE; Yang LH; Park JK; Pan YF; Kim Y; Lee YJ; Xu ZY; Clemens JD
J Infect Dis; 2001 Jun; 183(12):1775-80. PubMed ID: 11372030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]